Stage IB Pancreatic Cancer Recruiting Phase 2 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0034490 (Stage IB Pancreatic Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03073785Hypofractionated Stereotactic Body Radiation Therapy and Fluorouracil or Capecitabine With or Without Zoledronic Acid in Treating Patients With Locally Advanced Pancreatic CancerTreatment